Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
Volume: 19, Issue: 7, Pages: 1819 - 1822
Published: Jul 1, 2021
Abstract
Cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have been reported. The term vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) was coined to reflect this new phenomenon. In vitro experiments with VIPIT patient sera indicated that high-dose intravenous immunoglobulins (IVIG) competitively inhibit the platelet-activating properties of ChAdOx1 nCoV-19 vaccine induced...
Paper Details
Title
Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
Published Date
Jul 1, 2021
Volume
19
Issue
7
Pages
1819 - 1822
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History